Gimv is investing $14.5 million along with existing shareholders and the founder, Pierre Chappaz.
Read More

Firm backed by angel investors including San Francisco-based seed fund Amicus Capital.
Read More

Participating in the financing are previous investors, NEA, CMEA and certain individual investors, as well as a new investor, Amgen Ventures.
Read More

New fund will acquire healthcare royalty streams and provides structured debt capital to healthcare companies.
Read More